The safety, tolerability and risks associated with the use of newer generation antidepressant drugs: a critical review of the literature

AF Carvalho, MS Sharma, AR Brunoni… - Psychotherapy and …, 2016 - karger.com
Newer generation antidepressant drugs (ADs) are widely used as the first line of treatment
for major depressive disorders and are considered to be safer than tricyclic agents. In this …

Evidence-based guidelines for the pharmacological treatment of schizophrenia: updated recommendations from the British Association for Psychopharmacology

TRE Barnes, R Drake, C Paton… - Journal of …, 2020 - journals.sagepub.com
These updated guidelines from the British Association for Psychopharmacology replace the
original version published in 2011. They address the scope and targets of pharmacological …

[图书][B] The American Psychiatric Association practice guideline for the treatment of patients with schizophrenia

American Psychiatric Association - 2020 - books.google.com
The American Psychiatric Association Practice Guideline for the Treatment of Patients With
Schizophrenia seeks to reduce these substantial psychosocial and public health …

Risk of breast cancer with prolactin elevating antipsychotic drugs: an observational study of US women (ages 18–64 years)

T Rahman, JM Sahrmann, MA Olsen… - Journal of clinical …, 2022 - journals.lww.com
Purpose/Background: Antipsychotic drugs are well established to alter circulating prolactin
levels by blocking dopamine D2 receptors in the pituitary. Prolactin activates many genes …

Cancer mortality in patients with schizophrenia: systematic review and meta-analysis

C Zhuo, R Tao, R Jiang, X Lin, M Shao - The British Journal of …, 2017 - cambridge.org
BackgroundPrevious studies have reported conflicting results on the association between
schizophrenia and cancer mortality. AimsTo summarise available evidence and quantify the …

Risk of cancer in bipolar disorder and the potential role of lithium: International collaborative systematic review and meta-analyses

G Anmella, G Fico, M Lotfaliany… - Neuroscience & …, 2021 - Elsevier
We examined bipolar disorder (BD) as a risk factor for developing cancer and the role of
lithium on cancer incidence. We conducted two systematic review and meta-analyses of …

[HTML][HTML] The forgotten effects of thyrotropin-releasing hormone: Metabolic functions and medical applications

E Fröhlich, R Wahl - Frontiers in neuroendocrinology, 2019 - Elsevier
Thyrotropin-releasing hormone (TRH) causes a variety of thyroidal and non-thyroidal effects,
the best known being the feedback regulation of thyroid hormone levels. This was employed …

Hyperprolactinemia-inducing antipsychotics increase breast cancer risk by activating JAK-STAT5 in precancerous lesions

AN Johnston, W Bu, S Hein, S Garcia, L Camacho… - Breast Cancer …, 2018 - Springer
Background Psychiatric medications are widely prescribed in the USA. Many antipsychotics
cause serum hyperprolactinemia as an adverse side effect; prolactin-Janus kinase 2 (JAK2) …

Advancements in biosensing of hormones: Recent progress and future trends

MB Behyar, A Mirzaie, M Hasanzadeh… - TrAC Trends in Analytical …, 2024 - Elsevier
Hormones play a crucial role as signaling molecules, produced by different glands in the
body and transported through the bloodstream to target organs, tissues, and cells. Disorders …

Use of antipsychotics and risk of breast cancer: a Danish nationwide case–control study

A Pottegård, TL Lash, D Cronin‐Fenton… - British Journal of …, 2018 - Wiley Online Library
Aims Some antipsychotics increase prolactin levels, which might increase the risk of breast
cancer. Existing evidence is conflicting and based on sparse data, especially for the …